Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Weber

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Neurology|June 17, 2017
Primary Progressive Multiple Sclerosis: Putting Together the PuzzleAhmed Abdelhak, Martin S Weber, Hayrettin Tumani
Expert Review of Neurotherapeutics|February 22, 2019
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment optionsIoanna Giotaki, Peter Lange, Martin S Weber
JAMA Neurology|February 13, 2023
Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A ReviewSarah Dybowski, Sebastian Torke, Martin S Weber
Experimental & Molecular Medicine|February 13, 2026
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro modelsAlica Blenkle, Anastasia Geladaris, Martin S Weber
Current Neurology and Neuroscience Reports|March 6, 2016
The Use of Oral Disease-Modifying Therapies in Multiple SclerosisBenedikt Kretzschmar, Hannah Pellkofer, Martin S Weber
Biochimica Et Biophysica Acta|July 6, 2010
The role of antibodies in multiple sclerosisMartin S Weber, Bernhard Hemmer, Sabine Cepok
Pharmaceuticals (Basel, Switzerland)|January 9, 2021
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum DisordersJan Traub, Leila Husseini, Martin S Weber
Frontiers in Immunology|March 13, 2020
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating DiseaseDarius Häusler, Sebastian Torke, Martin S Weber
CNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Neurology|June 17, 2017
Primary Progressive Multiple Sclerosis: Putting Together the PuzzleAhmed Abdelhak, Martin S Weber, Hayrettin Tumani
Expert Review of Neurotherapeutics|February 22, 2019
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment optionsIoanna Giotaki, Peter Lange, Martin S Weber
JAMA Neurology|February 13, 2023
Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A ReviewSarah Dybowski, Sebastian Torke, Martin S Weber
Experimental & Molecular Medicine|February 13, 2026
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro modelsAlica Blenkle, Anastasia Geladaris, Martin S Weber
Current Neurology and Neuroscience Reports|March 6, 2016
The Use of Oral Disease-Modifying Therapies in Multiple SclerosisBenedikt Kretzschmar, Hannah Pellkofer, Martin S Weber
Biochimica Et Biophysica Acta|July 6, 2010
The role of antibodies in multiple sclerosisMartin S Weber, Bernhard Hemmer, Sabine Cepok
Pharmaceuticals (Basel, Switzerland)|January 9, 2021
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum DisordersJan Traub, Leila Husseini, Martin S Weber
Frontiers in Immunology|March 13, 2020
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating DiseaseDarius Häusler, Sebastian Torke, Martin S Weber
CNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Pageof 14